Causes of Hypophosphatemia with Hyperphosphaturia
Hypophosphatemia with hyperphosphaturia (renal phosphate wasting) is caused by either FGF23-mediated disorders or primary renal tubular defects, with the key discriminant being the FGF23 level. 1
Algorithmic Approach Based on FGF23 Levels
The diagnostic pathway hinges on measuring intact FGF23 levels in the setting of hypophosphatemia with documented renal phosphate wasting 1:
If FGF23 is NOT Suppressed (Normal or Elevated):
These are FGF23-mediated disorders where FGF23 inappropriately remains elevated despite hypophosphatemia:
Genetic Causes (80% is X-linked hypophosphatemia):
- X-linked hypophosphatemia (XLH) - accounts for ~80% of cases with non-suppressed FGF23 1
- Autosomal-dominant hypophosphatemic rickets
- Autosomal-recessive hypophosphatemic rickets (types 1 and 2)
- Raine syndrome
- Hypophosphatemic rickets with hyperparathyroidism 1
Acquired Causes:
- Tumor-induced osteomalacia - mesenchymal tumors secreting FGF23 1, 2
- Intravenous iron therapy (ferric carboxymaltose or iron isomaltoside) - causes "6H-syndrome": high FGF23, hyperphosphaturia, hypophosphatemia, hypovitaminosis D, hypocalcemia, and secondary hyperparathyroidism 1, 3
- Alcohol-induced FGF23 syndrome 1
- Ectopic FGF23 syndrome - rare complication in advanced prostate or lung cancer 1
- Fibrous dysplasia
- Cutaneous skeletal hypophosphatemia syndrome/epidermal nevus syndrome
- Osteoglophonic dysplasia
- Neurofibromatosis type 1 1
If FGF23 IS Suppressed (Low or Low-Normal):
These are primary renal tubular defects where the kidney appropriately suppresses FGF23 in response to hypophosphatemia:
Fanconi Syndrome Variants (generalized proximal tubular dysfunction):
- Cystinosis (prior to kidney failure)
- Dent disease (types 1 and 2)
- Hypophosphatemia with nephrocalcinosis
- Reno-tubular syndrome type 2
- Drug-induced (platinum-based chemotherapy, tyrosine kinase inhibitors) 4
- Tacrolimus-induced tubular dysfunction 3
Isolated Renal Phosphate Wasting:
- Hereditary hypophosphatemic rickets with hypercalciuria (HHRH) - distinguished by hypercalciuria, unlike other causes 1
- SLC34A1 or SLC34A3 mutations 2, 5
Secondary Causes:
- Primary hyperparathyroidism (elevated PTH with high calcium)
- Secondary hyperparathyroidism (elevated PTH with low calcium from vitamin D deficiency) 6
- Renal tubular acidosis 3
Critical Diagnostic Workup
To establish the diagnosis, the 2025 guidelines recommend 1:
Blood tests:
- Phosphate, calcium, creatinine, bicarbonate
- 25(OH) vitamin D, 1,25(OH) vitamin D
- PTH, alkaline phosphatase
- Intact FGF23 (critical discriminant)
Urine tests:
- Phosphate, calcium, creatinine (calculate TmP/GFR)
- Amino acids, glucose, low-molecular-weight proteins (to exclude Fanconi syndrome)
Essential exclusions before diagnosing genetic causes 1:
- Metabolic acidosis (measure bicarbonate)
- Hypercalciuria (distinguishes HHRH from other causes)
- Generalized Fanconi syndrome (aminoaciduria, glycosuria, proteinuria)
Common Pitfalls
Failing to measure FGF23 - This is the single most important test to differentiate FGF23-mediated from primary tubular causes 1
Missing iatrogenic causes - Always review recent medications, particularly IV iron (can cause delayed hypophosphatemia weeks after infusion) and denosumab 3
Overlooking tumor-induced osteomalacia - Consider in adults with new-onset hypophosphatemia and non-suppressed FGF23, especially without family history 2
Not excluding vitamin D deficiency and hyperparathyroidism - These common acquired causes must be ruled out first 1
Assuming genetic testing is definitive - About one-third of XLH patients have no family history due to de novo mutations, and genetic testing may reveal variants of uncertain significance 2, 5